TORONTO -- Apotex Inc. president and CEO Jeremy Desai resigned from the generic drug giant Friday while facing a lawsuit alleging he and the company accepted trade secrets leaked from a competitor.
The lawsuit from Teva Pharmaceutical Industries Ltd. accuses Barinder Sandhu, who worked as a senior director of regulatory affairs for Teva's U.S. generics division, of leaking trade secrets and other confidential information to Desai while being in a romantic relationship with him.
The allegations have not been proven in court and Apotex, Sandhu and Desai have filed motions to dismiss the complaint.
The lawsuit, filed last July in a Pennsylvania federal court, alleges Sandhu used email and USB drives to send Desai confidential information including the regulatory status of drugs and information on the development of a new generic drug.
The legal filings accuse Sandhu of uploading some 900 Teva corporate files to a cloud-based storage system between October 2014 and August 2016. (more...)
No comments:
Post a Comment